IRC Patient Organisation survey |
Introduction
The overall aim of the International Respiratory Coalition (IRC) is to promote lung health and improve respiratory care. The vision is for every country to have the tools to implement a national respiratory strategy based on best practice.
The IRC was launched by European Respiratory Society (ERS) together with the Global Allergy & Airways Patient Platform (GAAPP), AstraZeneca and Amgen in September 2021 at the ERS Congress. The IRC will be a multistakeholder initiative and will be open for others to join.
ELF wants to ensure that this initiative has patients at its heart. Therefore, in parallel with the ERS carrying out a survey with national respiratory societies, we would like to get the views and input of national patient organisations.
The survey has 13 questions and the answers you give will help inform the strategy and activities of the IRC.
The IRC was launched by European Respiratory Society (ERS) together with the Global Allergy & Airways Patient Platform (GAAPP), AstraZeneca and Amgen in September 2021 at the ERS Congress. The IRC will be a multistakeholder initiative and will be open for others to join.
ELF wants to ensure that this initiative has patients at its heart. Therefore, in parallel with the ERS carrying out a survey with national respiratory societies, we would like to get the views and input of national patient organisations.
The survey has 13 questions and the answers you give will help inform the strategy and activities of the IRC.